Endo-SPONGE treatment for lower pelvic anastomotic or Hartmann's stump leakages
Official title: A Prospective Multicenter Trial Evaluating the Safety and Effectiveness of Endo-SPONGE for the Treatment of Anastomotic or Hartmann's Stump Leakages in the Lower Pelvic Area
Run by Boston Scientific Corporation · NCT07035431 · Data updated 2026-11-12
This study will test whether Endo-SPONGE endoscopic vacuum therapy can safely help close anastomotic or Hartmann's stump leakages in adults after colorectal surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 66 (estimated) |
| Sponsor | Boston Scientific Corporation Industry-sponsored |
| Locations | 10 sites (Sacramento, California and 9 other locations) |
| Status | Recruiting |
| Started | November 2, 2026 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07035431 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with a confirmed grade B anastomotic or Hartmann's stump leak in the extraperitoneal lower pelvis, a transmural defect ≥2 cm, an existing or newly created diverting ostomy, and who are eligible for endoscopic intervention.
✕Probably not a fit
Patients under 18, pregnant or otherwise vulnerable individuals, those with leaks outside the extraperitoneal lower pelvis, defects smaller than 2 cm, or who are not candidates for endoscopic therapy are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a prospective, multicenter interventional study using sponge-based endoscopic vacuum therapy (Endo-SPONGE) to treat anastomotic or Hartmann's stump leakages in the lower pelvic area. Adults with confirmed grade B leaks, an extraperitoneal transmural defect of at least 2 cm, and a diverting ostomy are eligible and will undergo endoscopic placement of the sponge with serial exchanges until defect closure. The study will collect safety data and effectiveness outcomes such as leak closure rate, time to closure, and procedure-related adverse events. Procedures are performed at participating US centers with protocol-defined follow-up visits to document healing and complications.
Why it matters
Potential benefit: If successful, this approach could provide a less invasive option to close pelvic anastomotic or stump leaks, potentially avoiding additional major surgery and shortening recovery.
How similar studies have gone: Previous case series and cohort studies of endoscopic vacuum therapy and Endo-SPONGE have reported promising healing rates and safety, but randomized and large multicenter data remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Confirmed grade B anastomotic leak as per the ISGRC (International Study Group of Rectal Cancer) grading system after colorectal surgery. * Subject is eligible for endoscopic intervention. * Subject has a transmural defect of at least 2 cm in diameter following colorectal surgery in the lower pelvic area. * Subject has an anastomotic or Hartmann's stump leak located within an extraperitoneal cavity. * Subject has pre-existing diverting ostomy or an ostomy created prior to the first Endo-SPONGE placement. * Subject understands the trial requirements and is willing and able to comply with the study procedures, all protocol-required follow up evaluations and provide written informed consent to participate in the study. * Investigator decision that EVT is the most suitable treatment of the available treatment options. Exclusion Criteria: * Subject is under 18 years of age. * Potentially vulnerable subject, including, but not limited to pregnant women. * Subject has undergone EVT or other similar interventions for the current colorectal indication. * Subject had colorectal surgery more than 60 days prior to the planned study procedure. * Subject has any necrotic tissue that would require endoscopic debridement prior to Endo-SPONGE placement. * Subject has known contraindication for EVT as per the IB. * Subject is currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor.
Where it's running
-
Mount Sinai
New York, New York, United States Recruiting -
Penn State Health
Hershey, Pennsylvania, United States Recruiting -
University of Washington Medical Center
Seattle, Washington, United States Recruiting -
Marshall University Medical Center
Huntington, West Virginia, United States Recruiting -
University of California, Davis Medical Center
Sacramento, California, United States Not yet recruiting -
Orlando Regional Medical Center
Orlando, Florida, United States Not yet recruiting
Show 4 more locations
-
Cleveland Clinic Florida
Weston, Florida, United States Not yet recruiting -
Lahey Medical Center
Burlington, Massachusetts, United States Not yet recruiting -
Cleveland Clinic Foundation
Cleveland, Ohio, United States Not yet recruiting -
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States Not yet recruiting
Study contacts
- Principal investigator: Eric Pauli, MD — Penn State Health
- Study coordinator: Steve Fodem
- Email: Steve.Fodem@bsci.com
- Phone: 651-246-3094
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Biological mesh reinforcement for digestive tract reconstruction
This study tests whether inserting a biological mesh during alimentary tract reconstruction can reduce bleeding and complications after digestive surgery.
-
Predicting bowel leaks after colorectal surgery with a computer model and surgeon input
This study tests a computer model that predicts anastomotic leaks after colorectal surgery, and sees if adding surgeons’ intuition improves the predictions.
-
Signia circular stapler for left-sided colon, sigmoid, and rectal resections
This study will try the Signia circular stapler with Tri-Staple technology to see if it safely creates bowel reconnections in adults having left-sided colon, sigmoid, or rectal surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.